REDUCE-FMR: Regurgitant Volume Reduced With Device During Mitral Annuloplasty in HF
from Cardiology Today's Intervention
Patients with HF and functional mitral regurgitation who received a device during transcatheter indirect mitral annuloplasty had a reduction in regurgitant volume at one year, according to data from the REDUCE-FMR trial presented at TCT 2018. The reduction was seen in both the implanted and intention-to-treat patient populations.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063